Early human augmentation startups used Transcranial Direct Current Stimulation (TDCS) to create wearable devices that could induce specific mental states. One version acted as a stimulant, like "digital caffeine," while another induced relaxation, like "digital cannabis," by delivering low-voltage electricity to specific brain regions.

The performance ceiling for non-invasive Brain-Computer Interfaces (BCIs) is rising dramatically, not from better sensors, but from advanced AI. New models can extract high-fidelity signals from noisy data collected outside the skull, potentially making surgical implants like Neuralink unnecessary for sophisticated use cases.

Frontier AI labs like Meta, OpenAI, and Anthropic are ultimately tracking toward becoming biotechnology platforms. While the public focuses on large language models, the real competitive frontier involves dynamically reading and writing to human brain circuits non-invasively. By pairing AI with modalities like focused ultrasound, these companies aim to modulate motivation, alertness, and learning in real time by titrating activity in specific subcortical regions such as the nucleus accumbens.

The sci-fi allure of brain implants and embedded chips often overshadows practical alternatives. Ariel Poler argues that most desired functionalities, from interfacing with AI to carrying identification, can be achieved with less invasive external devices like advanced hearables or wearables, questioning the necessity of risky surgical augmentation for healthy individuals.

While Meta's Brain-to-QWERTY V2 is technically 'non-invasive' as it doesn't require surgery, the term is misleading. The technology relies on a massive, room-sized magnetoencephalography machine, showing the immense hardware challenges that remain before BCI becomes practical for consumer use.

Challenging Neuralink's implant-based BCI, Merge Labs is creating a new paradigm using molecules, proteins, and ultrasound. This less invasive approach aims for higher bandwidth by interfacing with millions of neurons, fundamentally rethinking how to connect brains to machines.

Dr. Casey Halpern argues that creating precise, non-invasive treatments like focused ultrasound or TMS for psychiatric disorders depends on invasive research. By placing electrodes deep in the brain, researchers can map the exact circuits responsible for symptoms. This invasive data is essential to define accurate targets for future non-invasive technologies.

While current brain-computer interfaces (BCIs) are for medical patients, the timeline for healthy individuals to augment their brains is rapidly approaching. A child who is five years old today might see the first healthy human augmentations before they graduate high school, signaling a near-term, transformative shift for society.

While 'reading' from the nervous system (e.g., HRV tracking) is common, 'writing' to it is the next step. Huberman predicts the first successful consumer applications will be for sleep, as the outcome is highly objective. Technologies like mechanically rocking beds or eye-movement-stimulating masks are early examples.